학술논문

Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 March 2024, 30(6):1111-1120)
Subject
Language
English
ISSN
15573265
10780432